SUGP1: A Protein Regulating DNA Replication and Potential Drug Target

Target Name: SUGP1

NCBI ID: G57794

SUGP1

SUGP1: A Protein Regulating DNA Replication and Potential Drug Target

SUGP1 (short for uridine triphosphate), is a protein that is expressed in various tissues throughout the body. It is a key player in the regulation of DNA replication and has been identified as a potential drug target in the treatment of various diseases.

The SUGP1 protein is composed of four structural domains: an N-terminal alpha-helix, a beta-sheet, a beta-hicle, and a C-terminal Tudor domain. The N-terminal alpha-helix is 鈥嬧?媟esponsible for the protein's overall structure and functions as a nucleosome binding protein. The beta-sheet and beta-hicle domains are involved in the regulation of DNA replication and the binding of the protein to the replication complex. The C-terminal Tudor domain is responsible for the protein's stability and functions as a negative regulator.

SUGP1 has been shown to play a crucial role in the regulation of DNA replication in various organisms, including humans. Studies have shown that SUGP1 is highly expressed in various tissues, including the muscle, liver, and pancreas, and is involved in the regulation of DNA replication in these tissues.

One of the key functions of SUGP1 is its role in the regulation of DNA replication in cancer cells. SUGP1 has been shown to be highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. Studies have shown that SUGP1 is involved in the regulation of DNA replication in these cancers and that inhibition of SUGP1 function may be a potential therapeutic approach for cancer treatment.

Another potential function of SUGP1 is its role in the regulation of DNA replication in neurodegenerative diseases.SUGP1 has been shown to be involved in the regulation of DNA replication in various neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. the regulation of DNA replication in these diseases and that inhibition of SUGP1 function may be a potential therapeutic approach for neurodegenerative disease treatment.

In addition to its role in the regulation of DNA replication, SUGP1 has also been shown to play a role in the regulation of cell signaling pathways.SUGP1 has been shown to be involved in the regulation of various signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell signaling pathways and has been implicated in the development and progression of various diseases.

In conclusion, SUGP1 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of DNA replication in various organisms. Studies have shown that SUGP1 is highly expressed in various types of cancer and neurodegenerative diseases and that inhibition of SUGP1 function may be a potential approach therapeutic for these diseases. Further research is needed to fully understand the functions of SUGP1 and its potential as a drug target.

Protein Name: SURP And G-patch Domain Containing 1

Functions: Plays a role in pre-mRNA splicing

The "SUGP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SUGP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets